Pharmacogenomics: implications and considerations for pharmacists

Author： Brock Tina Penick   Valgus John M   Smith Scott R   Summers Kelly M  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.3, 2003-05, pp. : 321-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An evaluation of pharmacists’ expectations towards pharmacogenomics

By de Denus Simon   Letarte Nathalie   Hurlimann Thierry   Lambert Jean-Philippe   Lavoie Annie   Robb Laura   Sheehan Nancy L   Turgeon Jacques   Vadnais Barbara  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 165-175

Future Medicine

Access to resources Recommend Favorite

Arrhythmia Pharmacogenomics: Methodological Considerations

By  

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3734-3741

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacists to be key players in pharmacogenomics?

By  

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Contrast Media—Implications for Pharmacists

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 1, 2005-03 ,pp. : 33-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ethical considerations in clinical pharmacogenomics research

By Issa A.M.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 247-249

Elsevier

Access to resources Recommend Favorite